TrialCancer2025

Cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced non-small cell lung cancer with programmed cell death-ligand 1 ≥50.

Saadettin Kilickap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.